SATT AxLR
SATT AxLR
Governance
Services for companies
Annual reports
Assisting you
Researchers
Call-for-projects
Companies
Startups
Practical guide
Technology offerings
Invest
In our technologies
In our startups
Technologies
Startups
Technology websites
AxLR TV
Working with AxLR
Purchasing & public procurement
Join us
Our startups are hiring
Media
News
Agenda
Press kit
Communication kit
Contact
Home
Health & Biotechnology
AVAILABLE TECHNOLOGY | Nanobody – Schizophrenia – mGlu2
NANO4SCHIZO
En savoir +
NANO4SCHIZO
0
AVAILABLE TECHNOLOGY | Nanobody – Schizophrenia – mGlu2
IMIQUALINES
En savoir +
IMIQUALINES
5
AVAILABLE TECHNOLOGY | cancer – imiqualines
DOCK 5
En savoir +
DOCK 5
4
AVAILABLE TECHNOLOGY | Osteolytic diseases – Dock5 – NCE
LipoSTAR
En savoir +
LipoSTAR
4
AVAILABLE TECHNOLOGY | Lipophenols – Carbonyl and oxidative stresses – MMP-9
SPIMA
En savoir +
SPIMA
3
AVAILABLE TECHNOLOGY | Stapled Peptides – Inflammatory diseases – Oncology
TIX001
En savoir +
TIX001
0
AVAILABLE TECHNOLOGY | Prevention of the toxicity of DNA-damaging anti-cancer agents – Chemotherapy and radiotherapy – Improvement of anti-cancer treatment efficacy
GeniaTer-CMT1A
En savoir +
GeniaTer-CMT1A
0
MARKETED TECHNOLOGY | Gene therapy – Nontraumatic intraneural injection – CMT1A
TESOVIR
En savoir +
TESOVIR
0
AVAILABLE TECHNOLOGY | HIV Reservoir – Biomarkers – mAb
LRAs
En savoir +
LRAs
0
AVAILABLE TECHNOLOGY | HIV – Shock & Kill Strategy – LRAs
1
2
3
4
5
6
Suivant